Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_05-cv-01482/USCOURTS-caed-1_05-cv-01482-0/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Michael A. Garabed (SBN 223511)

REED SMITH LLP

1901 Avenue of the Stars, Suite 700

Los Angeles, CA 90067

Telephone: 310.734.5200

Facsimile: 310.734.5299

Attorneys for DUSA Pharmaceuticals, Inc. and

Queen's University at Kingston

UNITED STATES DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

DUSA PHARMACEUTICALS, INC., a New

Jersey corporation; and QUEEN'S

UNIVERSITY AT KINGSTON, a Canadian

academic organization.,

Plaintiffs,

vs.

SKIN DEEP d/b/a SKIN DEEP DERM &

LASER, a California company; and BIPIN

PATEL, M.D., a California citizen, personally

and including his marital estate,

Defendants.

No.: 05-CV-01482 AWI (SMS)

CONSENT JUDGMENT

CONSENT JUDGMENT

Plaintiffs DUSA Pharmaceuticals, Inc.® (“DUSA”) and Queen’s University at Kingston

(“Queen’s University”) (collectively “Plaintiffs”) and Defendants Skin Deep d/b/a Skin Deep

Derm & Laser (“Skin Deep”), and Bipin Patel, M.D. (“Dr. Patel”), personally and including his

Case 1:05-cv-01482-AWI -SMS Document 11 Filed 01/13/06 Page 1 of 4
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 2

marital estate, collectively (“Defendants”) having agreed to a settlement of the matters at issue

between them, hereby agree and consent to judgment as follows:

Plaintiffs’ above-captioned complaint is a civil action for patent infringement of United

States Patent Nos. 6,710,066 ("the '066 patent") and 5,955,490 (“the ‘490 patent”) under 35

U.S.C. §271(a).

Defendants admit each of the allegations contained in the above-captioned complaint,

specifically those allegations contained in paragraphs 1 through 15. 

Defendants admit that they practice medicine, advertises the practice, unfairly competes

with DUSA, and as part of that practice, infringes the ‘066 patent and the ‘490 patent.

Defendants accordingly consent and agree to be permanently enjoined from infringing

United States Patent No. 6,710,066 during the life of that patent, and in furtherance thereof will

not use aminolevulinic acid containing drug products from a source other than DUSA for

treatment of actinic keratosis. 

Defendants consent and agree to be permanently enjoined from infringing United States

Patent No. 5,955,490 during the life of that patent, and in furtherance thereof will not use

aminolevulinic acid containing drug products from a source other than DUSA to treat patients for

acne.

Defendants further consent and agree to make available for inspection by Plaintiffs

Defendants’ books and/or other records likely to establish whether Defendants are in compliance

with the terms of the Consent Judgment as set forth herein. Defendants shall make their books

and/or other records available for inspection by Plaintiff on request no more often than once per

year on reasonable notice, with the expense of inspection to be bourn by Plaintiffs, unless such

inspection reveals that Defendants are not in compliance with the consent judgment, in which

case the expense will be borne by Defendants. Such inspection shall include appropriate

safeguards for patient confidentiality.

Case 1:05-cv-01482-AWI -SMS Document 11 Filed 01/13/06 Page 2 of 4
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 3

Defendants consent and agree that Plaintiffs shall have the absolute right to enforce any

and all terms of this Consent Judgment by and through any means permitted under statutory

and/or common law.

Plaintiffs consent and agree to waive the entry of any monetary award in their favor and to

forego reimbursement by Defendants for attorney fees and costs, provided that Defendants

comply with each of the terms and conditions of this Consent Judgment as set forth herein. 

Defendants also consent and agree that in the event Defendants fails to comply with any or all

terms of this Consent Judgment, Plaintiffs shall have the absolute right to obtain from

Defendants awards previously waived, and all fees and costs associated with bringing the abovecaptioned action and from enforcing compliance with this Consent Judgment. 

We consent to this Judgment:

PLAINTIFFS DUSA PHARMACEUTICALS,

INC. and QUEEN’S UNIVERSITY AT

KINGSTON

_/s/ Michael A. Garabed__________________

Michael A. Garabed (SBN 223511)

REED SMITH LLP

1901 Avenue of the Stars, Suite 700

DEFENDANT BIPIN PATEL, MD 

__/s/ Bipin Patel________________________

Defendant Bipin Patel, MD 

Dated: December 15, 2005

Case 1:05-cv-01482-AWI -SMS Document 11 Filed 01/13/06 Page 3 of 4
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 4

Los Angeles, CA 90067

Telephone: 310.734.5200

Facsimile: 310.734.5299

Attorneys for DUSA Pharmaceuticals, Inc. and

Queen's University at Kingston

William J. McNichol, Jr.

Maryellen Feehery

Valerie Brand Pipano

Reed Smith LLP

2500 One Liberty Place

1650 Market Street Philadelphia, PA 19103

(215) 851-8100

Attorneys for Plaintiffs

Dated: December 16, 2005

DEFENDANT SKIN DEEP d/b/a/ SKIN DEEP

DERM & LASER 

By: _/s/ Bipin Patel_____________________

Name: Dr. Bipin Patel, MD

Title: M.D. 

Date: December 15, 2005

ORDER

IT IS SO ORDERED.

Dated: January 11, 2006 /s/ Anthony W. Ishii 

9h0d30 UNITED STATES DISTRICT JUDGE

Case 1:05-cv-01482-AWI -SMS Document 11 Filed 01/13/06 Page 4 of 4